Atlas Trials

Study Assessing Reduced HPV Infectivity and Transmission in HPV-Positive Women Following Vaccination With 9vHPV

Clinical trial NCT07303751 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07303751
Sponsor
Institut d'Investigació Biomèdica de Bellvitge
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
HPVHigh-risk HPV (Any Strain)Human Papillomavirus (HPV) Infections
Start date
2026-02-01
Primary completion
2027-02-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.